These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Chemotherapy as an adjunct to surgery in the treatment of pulmonary malignant disease. Mountain CF. Acta Chir Belg; 1971 Apr; 70(4):351-64. PubMed ID: 5143081 [No Abstract] [Full Text] [Related]
6. Coordinated treatment of childhood rhabdomyosarcoma with surgery, radiotherapy, and combination chemotherapy. Pratt CB, Hustu HO, Fleming ID, Pinkel D. Cancer Res; 1972 Mar; 32(3):606-10. PubMed ID: 4551437 [No Abstract] [Full Text] [Related]
7. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma]. Ryssel HJ, Hasler E, Sonntag RW, Cavalli F, Martin J, Tschopp L, Brunner KW. Schweiz Med Wochenschr; 1977 Jul 02; 107(26):912-5. PubMed ID: 877537 [Abstract] [Full Text] [Related]
8. Evaluation of the combination of hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in carcinoma of the lung. Weiss AJ, Wilson WL. Cancer Chemother Rep; 1971 Jun 02; 55(3):299-302. PubMed ID: 5115850 [No Abstract] [Full Text] [Related]
9. Chemotherapy for lung cancer at the Institute of Experimental and Clinical Oncology, Academy of Medical Sciences, USSR. Perevodchikova NI, Bychkov MB. Cancer Chemother Rep 3; 1973 Mar 02; 4(2):251-5. PubMed ID: 4199645 [No Abstract] [Full Text] [Related]
10. Combination chemotherapy of advanced lung cancer: a randomized trial. Hansen HH, Selawry OS, Simon R, Carr DT, van Wyk CE, Tucker RD, Sealy R. Cancer; 1976 Dec 02; 38(6):2201-7. PubMed ID: 187312 [Abstract] [Full Text] [Related]
11. Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell. Livingston RB. Cancer Treat Rev; 1977 Sep 02; 4(3):153-65. PubMed ID: 73419 [No Abstract] [Full Text] [Related]
13. Recent therapeutic developments in lung cancer. Hansen HH, Selawry OS. Med Ann Dist Columbia; 1971 Sep 02; 40(9):580-2. PubMed ID: 4939062 [No Abstract] [Full Text] [Related]
14. Radiotherapy for bronchogenic carcinoma: actual difficulties and plans for the future. Dana M. Cancer Chemother Rep 3; 1973 Mar 02; 4(2):153-5. PubMed ID: 4734076 [No Abstract] [Full Text] [Related]
16. Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma. Host H. Cancer Chemother Rep 3; 1973 Mar 02; 4(2):161-4. PubMed ID: 4729319 [No Abstract] [Full Text] [Related]
17. BCNU (NSC-409962) in the treatment of bronchogenic carcinoma. Whittington RM, Fairly JL, Majima H, Patno ME, Prentice R. Cancer Chemother Rep; 1972 Dec 02; 56(6):739-43. PubMed ID: 4574055 [No Abstract] [Full Text] [Related]
18. Chemotherapy of bronchogenic carcinomas by a combination of cyclophosphamide, methotrexate, vincristin and bleomycin. Schaerer R, Sotto JJ, Wiget U, Perdrix A, Bensa JC, Ribaud P. Eur J Cancer (1965); 1977 Dec 02; 13(4-5):425-8. PubMed ID: 68881 [No Abstract] [Full Text] [Related]
19. Chemotherapy in bronchogenic carcinoma. Ojala A, Nikkanen VN, Palojoki A, Paloheimo S. Ann Clin Res; 1977 Feb 02; 9(1):12-4. PubMed ID: 329741 [Abstract] [Full Text] [Related]
20. Split-course irradiation compared to split-course irradiation plus hydroxyurea in inoperable bronchogenic carcinoma--a randomized study of 53 patients. Landgren RC, Hussey DH, Barkley HT, Samuels ML. Cancer; 1974 Nov 02; 34(5):1598-601. PubMed ID: 4426027 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]